(Q41270730)

29 September 2017

1 reference

title

Anti-leukotriene agents: a new direction in asthma therapy (English)

1 reference

29 September 2017

Nathan RA

1

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

29 September 2017

1 reference

29 September 2017

volume

33

1 reference

29 September 2017

issue

6

1 reference

29 September 2017

page(s)

353-366

1 reference

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Measurement of immunoreactive leukotriene C4 in blood of asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

The late asthmatic response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Generation of leukotrienes by purified human lung mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Total Eosinophil Counts in the Management of Bronchial Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Eosinophilic Inflammation in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

The Role of Eosinophils in the Pathophysiology of Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Introduction of a nomenclature: Leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Release of leukotrienes in patients with bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

The effect of the oral leukotriene antagonist, ICI 204,219, on leukotriene D4 and histamine-induced cutaneous vascular reactions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Reduced nonspecific bronchial reactivity and decreased airway response to antigen challenge in atopic asthmatic patients treated with the inhaled leukotriene D4 antagonist, L‐648,051

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770909609068181

10.3109/02770909609068181

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference